| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| IVPInspire Veterinary Partners, Inc. | 4.51M | 0.05 | -0.02 | -0.5% | -76.75% | -286.48% | 10.48 |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Sales/Revenue | 0 | 2.55M | 9.83M | 16.68M | 16.59M |
| Revenue Growth % | - | - | 2.86% | 0.7% | -0% |
| Cost of Goods Sold | 0 | 1.72M | 7.29M | 13.12M | 13.3M |
| COGS % of Revenue | - | 0.67% | 0.74% | 0.79% | 0.8% |
| Gross Profit | 0 | 829.29K | 2.55M | 3.55M | 3.29M |
| Gross Margin % | - | 0.33% | 0.26% | 0.21% | 0.2% |
| Gross Profit Growth % | - | - | 2.07% | 0.4% | -0.07% |
| Operating Expenses | 5.52K | 1.88M | 6.06M | 10.73M | 12.32M |
| OpEx % of Revenue | - | 0.74% | 0.62% | 0.64% | 0.74% |
| Selling, General & Admin | 5.52K | 1.79M | 5.47M | 9.48M | 11.42M |
| SG&A % of Revenue | - | 0.7% | 0.56% | 0.57% | 0.69% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - |
| Other Operating Expenses | 0 | 84.47K | 596.12K | 1.25M | 898.23K |
| Operating Income | -5.52K | -1.05M | -3.52M | -7.17M | -9.03M |
| Operating Margin % | - | -0.41% | -0.36% | -0.43% | -0.54% |
| Operating Income Growth % | - | -188.71% | -2.36% | -1.04% | -0.26% |
| EBITDA | 0 | -962.76K | -2.91M | -5.76M | -7.36M |
| EBITDA Margin % | - | -0.38% | -0.3% | -0.35% | -0.44% |
| EBITDA Growth % | - | - | -2.02% | -0.98% | -0.28% |
| D&A (Non-Cash Add-back) | 5.52K | 84.47K | 609.59K | 1.41M | 1.67M |
| EBIT | -5.52K | -1.06M | -3.52M | -12.25M | -11.17M |
| Net Interest Income | 0 | -194.65K | -1.42M | -2.54M | -3.1M |
| Interest Income | 0 | 161 | 1.02K | 21 | 53 |
| Interest Expense | 0 | 194.81K | 1.43M | 2.54M | 3.1M |
| Other Income/Expense | 0 | -209.51K | -1.42M | -7.62M | -5.24M |
| Pretax Income | -5.52K | -1.26M | -4.94M | -14.79M | -14.26M |
| Pretax Margin % | - | -0.49% | -0.5% | -0.89% | -0.86% |
| Income Tax | 0 | 74.33K | -30.09K | 0 | 0 |
| Effective Tax Rate % | 1% | 1.06% | 0.99% | 1% | 1% |
| Net Income | -5.52K | -1.33M | -4.91M | -14.79M | -14.26M |
| Net Margin % | - | -0.52% | -0.5% | -0.89% | -0.86% |
| Net Income Growth % | - | -240.13% | -2.69% | -2.01% | 0.04% |
| Net Income (Continuing) | -5.52K | -1.33M | -4.91M | -14.79M | -14.26M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00 | -297.85 | -1099.13 | -5627.23 | -2.61 |
| EPS Growth % | - | - | -2.69% | -4.12% | 1% |
| EPS (Basic) | 0.00 | -297.85 | -1099.13 | -5627.23 | -2.61 |
| Diluted Shares Outstanding | 4.47K | 4.47K | 4.47K | 2.68K | 5.55M |
| Basic Shares Outstanding | 4.47K | 4.47K | 4.47K | 2.68K | 5.55M |
| Dividend Payout Ratio | - | - | - | - | - |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Total Current Assets | 21.97K | 2.39M | 1.74M | 1.35M | 2.02M |
| Cash & Short-Term Investments | 21.97K | 2.06M | 444.25K | 178.96K | 523.69K |
| Cash Only | 21.97K | 2.06M | 444.25K | 178.96K | 523.69K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 228.12K | 462.02K | 212.89K | 40.67K |
| Days Sales Outstanding | - | 32.66 | 17.15 | 4.66 | 0.89 |
| Inventory | 0 | 41K | 582.02K | 571.51K | 516.65K |
| Days Inventory Outstanding | - | 8.7 | 29.14 | 15.9 | 14.18 |
| Other Current Assets | 0 | 0 | 0 | 388.76K | -1 |
| Total Non-Current Assets | 0 | 3.94M | 18.44M | 20.44M | 18.17M |
| Property, Plant & Equipment | 0 | 2.04M | 8.07M | 9.57M | 8.26M |
| Fixed Asset Turnover | - | 1.25x | 1.22x | 1.74x | 2.01x |
| Goodwill | 0 | 1.61M | 7.61M | 8.15M | 8.02M |
| Intangible Assets | 0 | 239.19K | 2.73M | 2.51M | 1.63M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 51.25K | 29.46K | 212.9K | 254K |
| Total Assets | 21.97K | 6.33M | 20.19M | 21.79M | 20.2M |
| Asset Turnover | - | 0.40x | 0.49x | 0.77x | 0.82x |
| Asset Growth % | - | 287.11% | 2.19% | 0.08% | -0.07% |
| Total Current Liabilities | 0 | 2M | 7.25M | 7.58M | 8.2M |
| Accounts Payable | 0 | 44.89K | 1.02M | 3.21M | 1.98M |
| Days Payables Outstanding | - | 9.53 | 51.02 | 89.2 | 54.33 |
| Short-Term Debt | 0 | 1.5M | 5.45M | 3.28M | 5.75M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | -1 |
| Current Ratio | - | 1.19x | 0.24x | 0.18x | 0.25x |
| Quick Ratio | - | 1.17x | 0.16x | 0.10x | 0.18x |
| Cash Conversion Cycle | - | 31.84 | -4.73 | -68.64 | -39.25 |
| Total Non-Current Liabilities | 0 | 5.2M | 18.07M | 15M | 10.43M |
| Long-Term Debt | 0 | 5.2M | 17.41M | 13.48M | 8.49M |
| Capital Lease Obligations | 0 | 0 | 666.18K | 1.51M | 1.94M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 1 |
| Total Liabilities | 0 | 7.2M | 25.32M | 22.58M | 18.63M |
| Total Debt | 0 | 6.69M | 23.61M | 18.42M | 16.37M |
| Net Debt | -21.97K | 4.64M | 23.17M | 18.24M | 15.85M |
| Debt / Equity | - | - | - | - | 10.48x |
| Debt / EBITDA | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - |
| Interest Coverage | - | -5.38x | -2.47x | -2.83x | -2.91x |
| Total Equity | 21.97K | -869.09K | -5.14M | -788.26K | 1.56M |
| Equity Growth % | - | -40.56% | -4.91% | 0.85% | 2.98% |
| Book Value per Share | 4.92 | -194.51 | -1149.39 | -294.46 | 0.28 |
| Total Shareholders' Equity | 21.97K | -869.09K | -5.14M | -788.26K | 1.56M |
| Common Stock | 435 | 515 | 528 | 389 | 419 |
| Retained Earnings | -460 | -1.33M | -6.24M | -21.22M | -36.35M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Cash from Operations | -5.52K | -1.01M | -2.66M | -3.82M | -10.01M |
| Operating CF Margin % | - | -0.4% | -0.27% | -0.23% | -0.6% |
| Operating CF Growth % | - | -181.96% | -1.63% | -0.44% | -1.62% |
| Net Income | -5.52K | -1.33M | -4.91M | -14.79M | -14.26M |
| Depreciation & Amortization | 0 | 83.91K | 609.59K | 1.41M | 1.67M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 23.65K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 21.04K | 1.1M | 6.6M | 5.01M |
| Working Capital Changes | 0 | 216.15K | 548.81K | 2.96M | -2.44M |
| Change in Receivables | 0 | -228.12K | -233.9K | 125.62K | 172.21K |
| Change in Inventory | 0 | -41K | -230.13K | 84.91K | 12.42K |
| Change in Payables | 0 | 44.89K | 974.04K | 2.19M | -1.23M |
| Cash from Investing | 0 | -4.02M | -14.67M | -1.87M | -237.98K |
| Capital Expenditures | 0 | -1.31M | -134.97K | -383.73K | -237.98K |
| CapEx % of Revenue | - | 0.51% | 0.01% | 0.02% | 0.01% |
| Acquisitions | - | - | - | - | - |
| Investments | - | - | - | - | - |
| Other Investing | 0 | -51.25K | -20.02K | 0 | 0 |
| Cash from Financing | 269.16K | 7.07M | 15.71M | 5.63M | 10.59M |
| Debt Issued (Net) | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - |
| Other Financing | 269.16K | -162.73K | -260.61K | 1 | 4M |
| Net Change in Cash | - | - | - | - | - |
| Free Cash Flow | -5.52K | -2.32M | -2.84M | -4.2M | -10.24M |
| FCF Margin % | - | -0.91% | -0.29% | -0.25% | -0.62% |
| FCF Growth % | - | -419.38% | -0.22% | -0.48% | -1.44% |
| FCF per Share | -1.24 | -519.35 | -634.53 | -1570.60 | -1.85 |
| FCF Conversion (FCF/Net Income) | 1.00x | 0.76x | 0.54x | 0.26x | 0.70x |
| Interest Paid | 0 | 80.2K | 239.43K | 188.95K | 1.55M |
| Taxes Paid | 0 | 0 | 192.14K | 0 | 0 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | -25.13% | - | - | - | -3687.07% |
| Return on Invested Capital (ROIC) | - | -41.71% | -24.21% | -30.33% | -38.84% |
| Gross Margin | - | 32.53% | 25.88% | 21.31% | 19.84% |
| Net Margin | - | -52.22% | -49.94% | -88.71% | -85.97% |
| Debt / Equity | - | - | - | - | 10.48x |
| Interest Coverage | - | -5.38x | -2.47x | -2.83x | -2.91x |
| FCF Conversion | 1.00x | 0.76x | 0.54x | 0.26x | 0.70x |
| Revenue Growth | - | - | 285.81% | 69.56% | -0.5% |
| 2023 | 2024 | |
|---|---|---|
| Service | 11.88M | 12.19M |
| Service Growth | - | 2.60% |
| Product | 4.8M | 4.4M |
| Product Growth | - | -8.17% |
Inspire Veterinary Partners, Inc. (IVP) reported $15.6M in revenue for fiscal year 2024.
Inspire Veterinary Partners, Inc. (IVP) saw revenue decline by 0.5% over the past year.
Inspire Veterinary Partners, Inc. (IVP) reported a net loss of $11.9M for fiscal year 2024.
Inspire Veterinary Partners, Inc. (IVP) has a return on equity (ROE) of -3687.1%. Negative ROE indicates the company is unprofitable.
Inspire Veterinary Partners, Inc. (IVP) had negative free cash flow of $4.3M in fiscal year 2024, likely due to heavy capital investments.